Wide Ranks

EVGN

Evogene Ltd.

1.69

Top Statistics
Market Cap 11 M Forward PE -0.5424 Revenue Growth 39.80 %
Current Ratio 1.58 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -210.25 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.2640 Enterprise / Revenue 0.5490 Price To Sales Trailing12 Months 1.21
Profitability
Profit Margins -210.25 % Operating Margins -667.07 %
Balance Sheet
Total Cash 20 M Total Cash Per Share 4.10 Total Debt 810000
Total Debt To Equity 4.06 Current Ratio 1.58 Book Value Per Share 2.38
All Measures
Short Ratio 4.00 % Message Board Id finmb_3274115 Fax 972 8 946 6724
Shares Short Prior Month 14621 Return On Equity -0.8237 City Rehovot
Uuid bcca19aa-2c18-3b4d-b705-c438ae6f7284 Previous Close 1.62 First Trade Date Epoch Utc 1 B
Book Value 2.38 Beta 1.08 Total Debt 810000
Volume 63759 Price To Book 0.7079 Last Split Date 1 B
Fifty Two Week Low 1.44 Total Cash Per Share 4.10 Total Revenue 9 M
Shares Short Previous Month Date 1 B Target Median Price 8.12 Max Age 86400
Recommendation Mean 1.00 Sand P52 Week Change 0.3133 Operating Margins -667.07 %
Target Mean Price 8.12 Net Income To Common -19867000 Short Percent Of Float 0.0042
Implied Shares Outstanding 6 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 95480 Average Volume10days 95480 Total Cash 20 M
Next Fiscal Year End 1 B Revenue Per Share 1.88 Held Percent Insiders 0.0166
Ebitda Margins -208.19 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 1.62 Target Low Price 5.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 2.30 Open 1.62
Free Cashflow -2420875 Dividend Yield 0.00 % Return On Assets -0.2846
Time Zone Short Name EST Trailing Eps -4.46 Day Low 1.58
Address1 13 Gad Feinstein Street Shares Outstanding 6 M Price Hint 4
Target High Price 11.25 Website https://www.evogene.com 52 Week Change -0.7400
Average Volume 276912 Forward Eps -3.46 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 132.10 % Last Split Factor 1:10
Regular Market Day High 1.72 Is_sp_500 False Profit Margins -210.25 %
Debt To Equity 4.06 Fifty Two Week High 10.40 Day High 1.72
Shares Short 22354 Regular Market Open 1.62 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 0.5490 Revenue Growth 39.80 %
Shares Percent Shares Out 0.0042 Operating Cashflow -19807000 Currency USD
Time Zone Full Name America/New_York Market Cap 11 M Is_nasdaq_100 False
Zip 7638517 Quote Type EQUITY Industry Biotechnology
Long Name Evogene Ltd. Regular Market Day Low 1.58 Held Percent Institutions 0.1112
Current Price 1.69 Address2 Park Rehovot Enterprise To Ebitda -0.2640
Financial Currency USD Current Ratio 1.58 Gross Margins 81.42 %
Industry Disp Biotechnology Number Of Analyst Opinions 2 Country Israel
Float Shares 4 M Two Hundred Day Average 5.35 Enterprise Value 5 M
Price To Sales Trailing12 Months 1.21 Forward PE -0.5424 Regular Market Volume 63759
Ebitda -19672000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Evogene Ltd.

, together with its subsidiaries, operates as a computational biology company.

It focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through the use of its Computational Predictive Biology (CPB) platform.

The company operates through three segments: Agriculture, Human Health, and Industrial Applications.

The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance.

The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms.

The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses.

The company also provides medical cannabis products.

It operates in the United States, Israel, Brazil, and internationally.

Evogene Ltd.

was founded in 1999 and is headquartered in Rehovot, Israel.